.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The 2025/2026 influenza season saw the emergence of H3N2 subclade K, causing high infection rates and raising alarm over potential vaccine failure. However, new research suggests that H3N2 vaccine cross-reactivity remains largely preserved in adults. These findings provide much-needed clarity for clinicians advising patients on the efficacy of seasonal vaccination.
Initially, ferret-based studies predicted significant antigenic drift in subclade K, which often suggests reduced vaccine protection. Consequently, public health officials feared a major mismatch between circulating strains and the annual vaccine. Despite these predictions, real-world data in adult populations showed a different pattern. Researchers measured antibody responses in human sera to compare pre- and post-vaccination levels against both vaccine-like and subclade K isolates.
The study revealed that seasonal influenza vaccination effectively boosted antibody titres. Specifically, titres increased two-fold against the subclade K variants and three-fold against the vaccine-like strain. This indicates that the antigenic divergence between the circulating subclade K and the vaccine is limited. Furthermore, these results align with observed vaccine effectiveness in adults, suggesting that pre-existing immunity in humans plays a critical role.
One of the most significant takeaways from this research is the discrepancy between ferret models and human data. While ferrets are immunologically na\u00efve, most adults have a complex history of prior infections and vaccinations. Therefore, human serologic data provides a more accurate reflection of how a population will respond to a new variant. Incorporating this data into surveillance systems can significantly improve vaccine strain selection and public health planning.
Yes, research shows the seasonal vaccine induces a two-fold boost in antibody titres against subclade K, providing meaningful cross-reactivity despite minor genetic changes in the virus.
Ferrets used in labs are typically na\u00efve to the flu, whereas humans have \"immune imprinting\" from previous infections and vaccines, which helps maintain broader protection against new subvariants.
Disclaimer: This content is for informational and educational purposes only and is not intended as medical advice. It does not replace professional clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Wilson A et al. Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adults. EBioMedicine. 2026 Jun 12. doi: undefined. PMID: 42284681.
Centers for Disease Control and Prevention. Human Serology & Flu. Updated September 17, 2024. Accessed June 2026.
World Health Organization. Influenza (Seasonal). Fact Sheet. Accessed June 2026.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent study shows that seasonal vaccines boost antibody titres against H3N2 subclade K variants in adults. This research highlights why human serologic data is essential for accurate vaccine strain selection compared to ferret models.
2 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
